Making transfusion-transmitted malaria in Europe a thing of the past
Individuals requiring blood transfusion are a vulnerable population, often with debilitating conditions like cancer, and transfusion-transmitted malaria is often fatal.
Current serological tests used to identify “at risk” donors are not sensitive enough to completely eliminate malaria transfusion risk.
The current challenges are to optimise the testing strategy to minimise the loss of blood products (especially those rare blood phenotypes) and to enhance screening sensitivity for infectious immuno-tolerant donors who are difficult to identify.
**ECCMID has now changed its name to ESCMID Global, please credit ...













